Mesothelioma Diagnosis Study Guide 2026

Everything you need to pass the Mesothelioma Diagnosis exam in one place: the exam format, every topic to study, real practice questions with explanations, flashcards, and full-length practice tests. Free, no sign-up needed.

📋 Mesothelioma Diagnosis Exam Format at a Glance

100
Questions
120 min
Time Limit
70.00%
Passing Score

📚 Mesothelioma Diagnosis Topics to Study (21)

✍️ Sample Mesothelioma Diagnosis Questions & Answers

1. Which mesothelial lesion is classified as a precursor to mesothelioma and shows malignant cells confined to the mesothelial surface?
Mesothelioma in situ

Mesothelioma in situ (MIS) is a newly recognized WHO entity where malignant mesothelial cells are confined to the surface without stromal invasion, detected by BAP1 loss or CDKN2A deletion.

2. In the US, approximately how many new mesothelioma cases are diagnosed each year?
About 3,000

Approximately 3,000 new mesothelioma cases are diagnosed annually in the United States.

3. Which IHC marker is typically negative in mesothelioma but positive in metastatic breast carcinoma to the pleura?
GATA3

GATA3 is expressed in breast and urothelial carcinoma but is absent in mesothelioma, making it useful in distinguishing pleural metastases from primary mesothelioma.

4. What does an elevated serum CRP (C-reactive protein) indicate in the context of mesothelioma?
Active systemic inflammation associated with worse prognosis

Elevated CRP reflects tumor-driven systemic inflammation in mesothelioma and is an independent predictor of poor prognosis.

5. CT scan of the chest in pleural mesothelioma most characteristically shows which finding?
Circumferential pleural thickening

CT imaging typically reveals circumferential or nodular pleural thickening, often encasing the lung, which is highly characteristic of malignant pleural mesothelioma.

6. FISH (fluorescence in situ hybridization) for CDKN2A (p16) deletion is used in mesothelioma pathology to:
Distinguish malignant mesothelioma from benign mesothelial hyperplasia

Homozygous deletion of CDKN2A detected by FISH is a reliable molecular marker of malignancy in mesothelioma, distinguishing it from benign reactive proliferations.

🎯 Free Mesothelioma Diagnosis Practice Tests

📖 Mesothelioma Diagnosis Guides & Articles

Your Mesothelioma Diagnosis Study Path
1. Learn with Flashcards → 2. Drill Practice Tests → 3. Take the Full Exam Simulation